The molecular basis of variation in response to platelet activation by FcgRIIA: implications for the risk of thrombosis

Nicolson, Pip (Co-Investigator)
Watson, Steve (Co-Investigator)
Cunningham, Adam (Co-Investigator)
Montague, Samantha (Principal Investigator)

Cardiovascular Sciences

Short title	The molecular basis of variation in response to platelet activation by FcgRIIA: implications for the risk of thrombosis
Status	Active
Effective start/end date	17/07/23 → 16/07/26

Funding

British Heart Foundation

1 Article

Trivalent nanobody-based ligands mediate powerful activation of GPVI, CLEC-2 and PEAR1 in human platelets whereas FcγRIIA requires a tetravalent ligand
Martin, E., Clark, J., Montague, S., Moran, L. A., Di, Y., Bull, L. J., Whittle, L., Raka, F., Buka, R., Zafar, I., Kardeby, C., Slater, A. & Watson, S., 1 Jan 2024, In: Journal of Thrombosis and Haemostasis. 22, 1, p. 271-285
Research output: Contribution to journal › Article › peer-review

Open Access
File
12 Downloads (Pure)